The use of advanced biological and tissue-engineered wound products

Nurs Stand. 2006 Oct 25-31;21(7):68, 70, 72 passim. doi: 10.7748/ns2006.10.21.7.68.c6364.

Abstract

This article aims to reintroduce readers to biologically based and tissue-engineered wound management products. Indications for their use in clinical practice are suggested. It also examines two well-established wound management interventions, topical negative pressure therapy and larval therapy, which could have a positive effect on the outcome of biologically based and tissue-engineered wound management products.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Animals
  • Biological Factors / therapeutic use*
  • Cellulose / therapeutic use
  • Chondroitin Sulfates / therapeutic use
  • Coated Materials, Biocompatible / therapeutic use
  • Collagen / therapeutic use
  • Debridement
  • Diptera
  • Humans
  • Hyaluronic Acid / therapeutic use
  • Intercellular Signaling Peptides and Proteins / therapeutic use
  • Keratinocytes / physiology
  • Larva
  • Skin Care / methods*
  • Skin, Artificial* / statistics & numerical data
  • Suction
  • Tissue Engineering* / methods
  • Tissue Engineering* / statistics & numerical data
  • Treatment Outcome
  • Wound Healing / drug effects
  • Wound Healing / physiology
  • Wounds and Injuries / therapy*

Substances

  • Adjuvants, Immunologic
  • Alloderm
  • Apligraf
  • Biological Factors
  • Coated Materials, Biocompatible
  • Intercellular Signaling Peptides and Proteins
  • TransCyte
  • integra artificial skin
  • Cellulose
  • Hyaluronic Acid
  • Chondroitin Sulfates
  • Collagen